The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Evidence of β-Cell Dedifferentiation in Human Type 2 Diabetes
Open accessAbstract
CONTEXT: Diabetes is associated with a deficit of insulin-producing β-cells. Animal studies show that β-cells become dedifferentiated in diabetes, reverting to a progenitor-like stage, and partly converting to other endocrine cell types. OBJECTIVE: To determine whether similar processes occur in human type 2 diabetes, we surveyed pancreatic islets from 15 diabetic and 15 nondiabetic organ donors. DESIGN: We scored dedifferentiation using markers of endocrine lineage, β-cell-specific transcription factors, and a newly identified endocrine progenitor cell marker, aldehyde dehydrogenase 1A3. RESULTS: By these criteria, dedifferentiated cells accounted for 31.9% of β-cells in type 2 diabetics vs 8.7% in controls, and for 16.8% vs 6.5% of all endocrine cells (P < .001). The number of aldehyde dehydrogenase 1A3-positive/hormone-negative cells was 3-fold higher in diabetics compared with controls. Moreover, β-cell-specific transcription factors were ectopically found in glucagon- and somatostatin-producing cells of diabetic subjects. CONCLUSIONS: The data support the view that pancreatic β-cells become dedifferentiated and convert to α- and δ-"like" cells in human type 2 diabetes. The findings should prompt a reassessment of goals in the prevention and treatment of β-cell dysfunction.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy
Kahn, S. E., Haffner, S. M., Heise, M. A., Herman, W. H., Holman, R. R., Jones, N. P., Kravitz, B. G., Lachin, J. M., O'Neill, M. C., Zinman, B., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa066224 · Cited by 2,962
Weyer, C., Bogardus, C., Mott, D. M., & Pratley, R. E. (1999) · Journal of Clinical Investigation · doi:10.1172/jci7231 · Cited by 1,940
Pancreatic β Cell Dedifferentiation as a Mechanism of Diabetic β Cell Failure
Talchai, C., Xuan, S., Lin, H. V., Sussel, L., & Accili, D. (2012) · Cell · doi:10.1016/j.cell.2012.07.029 · Cited by 1,415
Self-citationNauck, M. A., Kleine, N., �rskov, C., Holst, J. J., Willms, B., & Creutzfeldt, W. (1993) · Diabetologia · doi:10.1007/bf00401145 · Cited by 1,092
Weng, J., Li, Y., Xu, W., Shi, L., Zhang, Q., Zhu, D., Hu, Y., Zhou, Z., Yan, X., Tian, H., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60762-x · Cited by 780
Pancreatic β‐cell mass in European subjects with type 2 diabetes
Rahier, J., Guiot, Y., Goebbels, R. M., Sempoux, C., & Henquin, J. C. (2008) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2008.00969.x · Cited by 756
β-Cell Failure in Diabetes and Preservation by Clinical Treatment
Wajchenberg, B. L. (2007) · Endocrine Reviews · doi:10.1210/10.1210/er.2006-0038 · Cited by 714
Selective β-Cell Loss and α-Cell Expansion in Patients with Type 2 Diabetes Mellitus in Korea
Yoon, K. H., Ko, S. H., Cho, J. H., Lee, J. M., Ahn, Y. B., Song, K. H., Yoo, S. J., Kang, M. I., Cha, B. Y., Lee, K. W., et al. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020735 · Cited by 649
FoxO1 protects against pancreatic β cell failure through NeuroD and MafA induction
Kitamura, Y. I., Kitamura, T., Kruse, J.-P., Raum, J. C., Stein, R., Gu, W., & Accili, D. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.08.004 · Cited by 556
Self-citationInactivation of specific β cell transcription factors in type 2 diabetes
Guo, S., Dai, C., Guo, M., Taylor, B., Harmon, J. S., Sander, M., Robertson, R. P., Powers, A. C., & Stein, R. (2013) · Journal of Clinical Investigation · doi:10.1172/jci65390 · Cited by 520
Aldehyde dehydrogenase: Its role as a cancer stem cell marker comes down to the specific isoform
Marcato, P., Dean, C. A., Giacomantonio, C. A., & Lee, P. W. K. (2011) · Cell Cycle · doi:10.4161/cc.10.9.15486 · Cited by 516
Functional and Molecular Defects of Pancreatic Islets in Human Type 2 Diabetes
Del Guerra, S., Lupi, R., Marselli, L., Masini, M., Bugliani, M., Sbrana, S., Torri, S., Pollera, M., Boggi, U., Mosca, F., et al. (2005) · Diabetes · doi:10.2337/diabetes.54.3.727 · Cited by 466
Self-citationThe endoplasmic reticulum in pancreatic beta cells of type 2 diabetes patients
Marchetti, P., Bugliani, M., Lupi, R., Marselli, L., Masini, M., Boggi, U., Filipponi, F., Weir, G. C., Eizirik, D. L., & Cnop, M. (2007) · Diabetologia · doi:10.1007/s00125-007-0816-8 · Cited by 413
Self-citationPancreatic β Cell Dedifferentiation in Diabetes and Redifferentiation following Insulin Therapy
Wang, Z., York, N. W., Nichols, C. G., & Remedi, M. S. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.03.010 · Cited by 406
Dunning, B. E., & Gerich, J. E. (2007) · Endocrine Reviews · doi:10.1210/er.2006-0026 · Cited by 369
Autophagy in human type 2 diabetes pancreatic beta cells
Masini, M., Bugliani, M., Lupi, R., del Guerra, S., Boggi, U., Filipponi, F., Marselli, L., Masiello, P., & Marchetti, P. (2009) · Diabetologia · doi:10.1007/s00125-009-1347-2 · Cited by 360
Self-citationNkx6.1 Is Essential for Maintaining the Functional State of Pancreatic Beta Cells
Taylor, B. L., Liu, F.-F., & Sander, M. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.08.010 · Cited by 345
Mutant Neurogenin-3 in Congenital Malabsorptive Diarrhea
Wang, J., Cortina, G., Wu, S. V., Tran, R., Cho, J.-H., Tsai, M.-J., Bailey, T. J., Jamrich, M., Ament, M. E., Treem, W. R., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa054288 · Cited by 320
Rovira, M., Scott, S.-G., Liss, A. S., Jensen, J., Thayer, S. P., & Leach, S. D. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0912589107 · Cited by 290
The replication of β cells in normal physiology, in disease and for therapy
Butler, P. C., Meier, J. J., Butler, A. E., & Bhushan, A. (2007) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0647 · Cited by 268
The Past 200 Years in Diabetes
Polonsky, K. S. (2012) · New England Journal of Medicine · doi:10.1056/nejmra1110560 · Cited by 264
Reversible changes in pancreatic islet structure and function produced by elevated blood glucose
Brereton, M. F., Iberl, M., Shimomura, K., Zhang, Q., Adriaenssens, A. E., Proks, P., Spiliotis, I. I., Dace, W., Mattis, K. K., Ramracheya, R., et al. (2014) · Nature Communications · doi:10.1038/ncomms5639 · Cited by 259
How Does Type 1 Diabetes Develop?
Atkinson, M. A., Bluestone, J. A., Eisenbarth, G. S., Hebrok, M., Herold, K. C., Accili, D., Pietropaolo, M., Arvan, P. R., Von Herrath, M., Markel, D. S., et al. (2011) · Diabetes · doi:10.2337/db10-1797 · Cited by 232
Self-citationWang, X., Misawa, R., Zielinski, M. C., Cowen, P., Jo, J., Periwal, V., Ricordi, C., Khan, A., Szust, J., Shen, J., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0067454 · Cited by 213
Insulin Resistance Alters Islet Morphology in Nondiabetic Humans
Mezza, T., Muscogiuri, G., Sorice, G. P., Clemente, G., Hu, J., Pontecorvi, A., Holst, J. J., Giaccari, A., & Kulkarni, R. N. (2014) · Diabetes · doi:10.2337/db13-1013 · Cited by 206
Lipotoxicity in Human Pancreatic Islets and the Protective Effect of Metformin
Lupi, R., Del Guerra, S., Fierabracci, V., Marselli, L., Novelli, M., Patanè, G., Boggi, U., Mosca, F., Piro, S., Del Prato, S., et al. (2002) · Diabetes · doi:10.2337/diabetes.51.2007.s134 · Cited by 186
Self-citationThe Stunned β Cell: A Brief History
Ferrannini, E. (2010) · Cell Metabolism · doi:10.1016/j.cmet.2010.04.009 · Cited by 175
Conversion of Mature Human β-Cells Into Glucagon-Producing α-Cells
Spijker, H. S., Ravelli, R. B. G., Mommaas, A. M., van Apeldoorn, A. A., Engelse, M. A., Zaldumbide, A., Bonner‐Weir, S., Rabelink, T. J., Hoeben, R. C., Clevers, H. C., et al. (2013) · Diabetes · doi:10.2337/db12-1001 · Cited by 151
Savage, P. J., Bennion, L. J., Flock, E. V., NAGULESPARAN, M., Mott, D. M., Roth, J., Unger, R. H., & Bennett, P. H. (1979) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-48-6-999 · Cited by 139
Are we overestimating the loss of beta cells in type 2 diabetes?
Marselli, L., Suleiman, M., Masini, M., Campani, D., Bugliani, M., Syed, F., Martino, L., Focosi, D., Scatena, F., Olimpico, F., et al. (2014) · Diabetologia · doi:10.1007/s00125-013-3098-3 · Cited by 136
Self-citationIMPROVEMENT IN INSULIN SECRETION IN DIABETES AFTER DIAZOXIDE
Greenwood, R. H., Mahler, R., & Hales, C. N. (1976) · The Lancet · doi:10.1016/s0140-6736(76)91473-2 · Cited by 118
White, M. G., Marshall, H. L., Rigby, R., Huang, G. C., Amer, A. O., Booth, T. A., White, S., & Shaw, J. (2013) · Diabetes Care · doi:10.2337/dc13-0705 · Cited by 110
Prevention of Diabetes With Pioglitazone in ACT NOW
DeFronzo, R. A., Tripathy, D., Schwenke, D. C., Banerji, M., Bray, G. A., Buchanan, T. A., Clement, S. C., Gastaldelli, A., Henry, R. R., Kitabchi, A. E., et al. (2013) · Diabetes · doi:10.2337/db13-0265 · Cited by 109
Bugliani, M., Liechti, R., Cheon, H., Suleiman, M., Marselli, L., Kirkpatrick, C. L., Filipponi, F., Boggi, U., Xénarios, I., Syed, F., et al. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2012.12.001 · Cited by 99
Self-citationKim-Muller, J. Y., Zhao, S., Srivastava, S., Mugabo, Y., Noh, H. L., Kim, Y., Madiraju, S. R. M., Ferrante, A. W., Skolnik, E. Y., Prentki, M., et al. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.08.012 · Cited by 98
Self-citationBeta-Cell Dedifferentiation and Type 2 Diabetes
Dor, Y., & Gläser, B. (2013) · New England Journal of Medicine · doi:10.1056/nejmcibr1214034 · Cited by 94
Puri, S., Akiyama, H., & Hebrok, M. (2013) · Genes & Development · doi:10.1101/gad.227785.113 · Cited by 80
Genetic and biochemical pathways of β‐cell failure in type 2 diabetes
Talchai, S. C., Lin, H. V., Kitamura, T., & Accili, D. (2009) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2009.01115.x · Cited by 66
Self-citationEffect of forkhead box O1 (FOXO1) on beta cell development in the human fetal pancreas
Al‐Masri, M., Krishnamurthy, M., Li, J., Fellows, G. F., Dong, H. H., Goodyer, C. G., & Wang, R. (2009) · Diabetologia · doi:10.1007/s00125-009-1632-0 · Cited by 56
Regulation of Pancreatic Juxtaductal Endocrine Cell Formation by FoxO1
Kitamura, T., Kitamura, Y., Kobayashi, M., Kikuchi, O., Sasaki, T., DePinho, R. A., & Accili, D. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.01622-08 · Cited by 53
Self-citationUltrastructural morphometric analysis of insulin secretory granules in human type 2 diabetes
Masini, M., Marselli, L., Bugliani, M., Martino, L., Masiello, P., Marchetti, P., & Tata, V. D. (2012) · Acta Diabetologica · doi:10.1007/s00592-012-0446-6 · Cited by 43
Self-citationLi, J., Feng, Z. C., Yeung, F. S.-H., Wong, M. R.-M., Oakie, A., Fellows, G. F., Goodyer, C. G., Hess, D. A., & Wang, R. (2013) · Diabetologia · doi:10.1007/s00125-013-3147-y · Cited by 38
Lukinius, A., Stridsberg, M., & Wilander, E. (2003) · Pancreas · doi:10.1097/00006676-200307000-00006 · Cited by 34
Suzuki, T., Kadoya, Y., Sato, Y., Handa, K., Takahashi, T., Kakita, A., & Yamashina, S. (2003) · Archivum histologicum japonicum · doi:10.1679/aohc.66.347 · Cited by 20
Mary, Mary, Quite Contrary, How Do Your β-Cells Fail?
Leahy, J. L. (2008) · Diabetes · doi:10.2337/db08-0869 · Cited by 16
Long in the shade, glucagon re‐occupies centre court
Henquin, J. C., Accili, D., Åhrén, B., Boîtard, C., Seino, S., & Cerasi, E. (2011) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2011.01476.x · Cited by 10
Self-citationUKPDS 26: sulphonylurea failure in non-insulin-dependent diabetic patients over six years
UK Prospective Diabetes Study (UKPDS) Group, Matthews, D. R., Cull, C. A., Stratton, I. M., Holman, R. R., & Turner, R. C. (1998) · Diabetic Medicine · doi:10.1002/(sici)1096-9136(199804)15:4
Cited by
Glucagon-like peptide 1 (GLP-1)
Müller, T. D., Finan, B., Bloom, S. R., D'Alessio, D., Drucker, D. J., Flatt, P. R., Fritsche, A., Gribble, F., Grill, H. J., Habener, J. F., et al. (2019) · Molecular Metabolism · doi:10.1016/j.molmet.2019.09.010 · Cited by 1,868
Pancreatic β-cells in type 1 and type 2 diabetes mellitus: different pathways to failure
Eizirik, D. L., Pasquali, L., & Cnop, M. (2020) · Nature Reviews Endocrinology · doi:10.1038/s41574-020-0355-7 · Cited by 854
Type 2 diabetes mellitus in adults: pathogenesis, prevention and therapy
Lu, X., Xie, Q., Pan, X., Zhang, R., Zhang, X., Peng, G., Zhang, Y., Shen, S., & Tong, N. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01951-9 · Cited by 665
Mechanisms controlling pancreatic islet cell function in insulin secretion
Campbell, J. E., & Newgard, C. B. (2021) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-00317-7 · Cited by 629
The Effects of Type 2 Diabetes Mellitus on Organ Metabolism and the Immune System
Daryabor, G., Atashzar, M. R., Kabelitz, D., Meri, S., & Kalantar, K. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01582 · Cited by 581
Metadata
- Authors
- Cinti, F., Bouchi, R., Kim-Muller, J. Y., Ohmura, Y., Sandoval, P. R., Masini, M., Marselli, L., Suleiman, M., Ratner, L. E., Marchetti, P., & Accili, D.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2016-03
- Volume
- 101
- Issue
- 3
- Pages
- 1044-1054
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2199891677
- Cited by
- 550
- References
- 49
- FWCI
- 33.03
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.